Quantinno Capital Management LP lifted its position in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 114.3% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 122,800 shares of the semiconductor company’s stock after purchasing an additional 65,494 shares during the quarter. Quantinno Capital Management LP’s holdings in Synopsys were worth $48,688,000 at the end of the most recent reporting period.
Several other hedge funds have also bought and sold shares of the business. Sowell Financial Services LLC raised its holdings in shares of Synopsys by 2.0% in the 4th quarter. Sowell Financial Services LLC now owns 1,056 shares of the semiconductor company’s stock worth $496,000 after acquiring an additional 21 shares during the last quarter. Natural Investments LLC raised its stake in shares of Synopsys by 4.6% in the fourth quarter. Natural Investments LLC now owns 482 shares of the semiconductor company’s stock worth $226,000 after purchasing an additional 21 shares during the last quarter. Financial Management Professionals Inc. raised its stake in shares of Synopsys by 7.0% in the fourth quarter. Financial Management Professionals Inc. now owns 335 shares of the semiconductor company’s stock worth $157,000 after purchasing an additional 22 shares during the last quarter. Foronjy Financial LLC boosted its position in shares of Synopsys by 5.2% during the fourth quarter. Foronjy Financial LLC now owns 446 shares of the semiconductor company’s stock valued at $210,000 after buying an additional 22 shares during the last quarter. Finally, AGH Wealth Advisors LLC grew its holdings in Synopsys by 4.4% during the first quarter. AGH Wealth Advisors LLC now owns 569 shares of the semiconductor company’s stock worth $226,000 after buying an additional 24 shares in the last quarter. Institutional investors and hedge funds own 85.47% of the company’s stock.
Synopsys Stock Down 2.6%
SNPS stock opened at $373.69 on Thursday. The stock has a fifty day moving average of $449.23 and a 200-day moving average of $452.19. Synopsys, Inc. has a fifty-two week low of $366.00 and a fifty-two week high of $651.73. The company has a market capitalization of $71.55 billion, a price-to-earnings ratio of 86.50, a PEG ratio of 2.25 and a beta of 1.22. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.32 and a current ratio of 1.43.
Insiders Place Their Bets
In related news, CFO Shelagh Glaser sold 3,394 shares of the business’s stock in a transaction that occurred on Friday, June 12th. The shares were sold at an average price of $450.02, for a total transaction of $1,527,367.88. Following the completion of the transaction, the chief financial officer owned 14,358 shares of the company’s stock, valued at approximately $6,461,387.16. The trade was a 19.12% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Sassine Ghazi sold 14,603 shares of the stock in a transaction that occurred on Monday, June 15th. The stock was sold at an average price of $458.96, for a total transaction of $6,702,192.88. Following the completion of the sale, the chief executive officer owned 75,020 shares in the company, valued at $34,431,179.20. This represents a 16.29% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. 0.56% of the stock is owned by company insiders.
Wall Street Analyst Weigh In
A number of equities analysts have issued reports on SNPS shares. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Synopsys in a report on Monday, June 8th. Benchmark assumed coverage on shares of Synopsys in a research note on Wednesday, July 15th. They issued a “buy” rating and a $570.00 price objective for the company. Piper Sandler raised Synopsys from a “neutral” rating to an “overweight” rating and upped their target price for the company from $450.00 to $550.00 in a report on Tuesday, June 23rd. Wells Fargo & Company lifted their price target on Synopsys from $505.00 to $535.00 and gave the stock an “equal weight” rating in a report on Thursday, May 28th. Finally, Rosenblatt Securities upped their price objective on Synopsys from $530.00 to $575.00 and gave the company a “buy” rating in a research note on Tuesday, May 26th. Two equities research analysts have rated the stock with a Strong Buy rating, ten have given a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, Synopsys has an average rating of “Moderate Buy” and an average target price of $570.06.
More Synopsys News
Here are the key news stories impacting Synopsys this week:
- Positive Sentiment: Expanded Nvidia partnership supports AI growth. Nvidia is adding Synopsys to its Agent Toolkit ecosystem, helping automate chip and system design. The relationship could increase demand for Synopsys’ electronic design automation (EDA) software as semiconductor companies adopt agentic AI. Agentic AI Is Coming to Chip Design. Here Is Why Synopsys Stock Could Be the Biggest Beneficiary
- Positive Sentiment: AI alliances may strengthen Synopsys’ strategic position. Partnerships involving Nvidia, AMD, Microsoft and Intel are aimed at automating chip-design bottlenecks, potentially improving productivity for customers and reinforcing Synopsys’ central role in the semiconductor ecosystem. Synopsys Just Solved a Bottleneck You Didn’t Even Know Existed
- Positive Sentiment: Intel’s next-generation 14A process provides another validation point. Synopsys’ tools are already supporting Intel’s 14A chip-development efforts, highlighting the importance of its software in advanced semiconductor manufacturing. Intel’s 14A chips aren’t built yet: Synopsys is already there
- Neutral Sentiment: Recent results remain solid but acquisition-driven. Quarterly revenue rose 41.9% year over year to $2.28 billion and EPS exceeded expectations, largely reflecting the Ansys acquisition. Investors may be looking for stronger organic growth to support Synopsys’ premium valuation. Synopsys: How Agentic AI And Ansys Drive Long-Term Growth
- Negative Sentiment: The immediate decline appears tied more to market and valuation pressure than a new fundamental setback. Reports noted that Synopsys underperformed the broader market during the latest session, while its elevated earnings multiple and recent underperformance likely encouraged caution and profit-taking. No new earnings warning was cited. Here’s Why Synopsys Fell More Than Broader Market
About Synopsys
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Featured Stories
- Five stocks we like better than Synopsys
- Why SK hynix Could Be the Best AI Chip Stock to Buy Now
- Seagate Technology Stock Surges as Earnings Beat Silences AI Doubters
- Alphabet Is Down 18% From Its High After a Stellar Quarter—Overdone, or More Downside Ahead?
- Why Bloom Energy May Be the Most Important AI Infrastructure Stock
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
